Given the widespread axonal degeneration characteristic of APS, CSF and blood NfL may indirectly gauge the effectiveness of treatment, especially in CBS where a marked elevation of CSF and blood levels has been observed. This evidence concerns the gene NEFL and autoimmune polyendocrinopathy.